Sökresultat - DiVA

DiVA - Sökresultat - DiVA Portal

Foto. Granström & Sundquist akustisk gitarr. 60-tal, nylonsträngad, retro Foto. Gå till. PDF) Risk of Kari Hemminki Ovarian cancer is a heterogeneous disease.

Kari hemminki dkfz

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D‐69120 Heidelberg, Germany. Kari Hemminki, Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg 69120, Germany. Email: K.Hemminki@dkfz.de. Search for more papers by this author Kari Hemminki is a top-class researcher in the field of cancer epidemiology and cancer genomics, he is a professor emeritus of the German Cancer Research Center (Deutsches Krebsforschungszentrum – DKFZ) in Heidelberg, where he led the Division of Cancer Epidemiology from 2003 to 2019.

Quick Facts; Organization & Management; Supporters and Friends; Alumni; Life-Science Lab; How to find us; Translational Research. NCT; DKTK; KiTZ; HI-TRON Mainz; DKFZ Kari Hemminki 1 , Akseli Hemminki 2 , Asta Försti 3 , Kristina Sundquist 4 , Xinjun Li 4 Affiliations 1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Center for Primary Health Care Research, Lund University, Malmö, Sweden. Kari Hemminki 1 , Xinjun Li, Kristina Sundquist, Jan Sundquist Affiliation 1 Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.

Granström & Sundquist - Love Art Not People

Contact Akseli Hemminki. Akseli Hemminki Hemminki K; Mousavi SM; Brandt A; Ji J; Sundquist J. Liver and 21 Dec 2010 in relation to survival and TNM classes.

New Title

View in Article. 18 Oct 2020 Kari Hemminki as the ERA Chair Holder and also as the head of the Center ( Deutsches Krebsforschungszentrum – DKFZ) in Heidelberg, Varadi, Verena. Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld ,Heidelberg, Germany.

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D‐69120 Heidelberg, Germany. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D‐69120 Heidelberg, Germany Deutsches Krebsforschungszentrums (DKFZ), Heidelberg Abteilung Molekulargenetische Epidemiologie (Kari Hemminki, Asta Försti) Abteilung Biostatistik (Axel Benner) Kari Hemminki, Jianguang Ji und Asta Försti: Risks for Familial and Contralateral Breast Cancer Interact Multiplicatively and Cause a High Risk. Cancer Research, February 1, 2007 The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to 07.2012 - 09.2012: Intern at the Molecular Genetic Epidemiology lab, Dr. Kari Hemminki, German Cancer Research Center (DKFZ), Germany. 07.2011 - 08.2011: Intern at the Pharmaceutical Biology Department, Dr. Iman Gomaa, German University in Cairo (GUC), Egypt. Research Interests/Future Plans Corresponding Author. E-mail address: kari.hemminki@dkfz.de Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D‐69120 Heidelberg, Germany Yu, Hongyao / Hemminki, Kari.
Köpa annons instagram

Gå till. PDF) Risk of Kari Hemminki Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age at diagnosis and histology are limited. Such data can assist genetic counseling and Kari HEMMINKI | Cited by 56,362 | of German Cancer Research Center, Heidelberg (DKFZ) | Read 1617 publications | Contact Kari HEMMINKI Kari Hemminki Prof bei DKFZ Frankfurt am Main und Umgebung, Deutschland Forschung (7)Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany.

Endocr Relat Cancer 17(2): 329-34. To precisely identify the types of cancer in which diabetes plays a role, Kari Hemminki of DKFZ collaborated with colleagues* in Sweden and the USA in the largest study ever on cancer risks of Type 2 diabetics. The study included 125,126 Swedish citizens who were hospitalised due to problems associated with Type 2 diabetes. Deutsches Krebsforschungszentrums (DKFZ), Heidelberg Abteilung Molekulargenetische Epidemiologie (Kari Hemminki, Asta Försti) Abteilung Biostatistik (Axel Benner) Luyao Zhang 1 2 , Otto Hemminki 3 4 , Tianhui Chen 5 , Guoqiao Zheng 1 2 , Asta Försti 1 6 , Kristina Sundquist 6 7 8 , Jan Sundquist 6 7 8 , Kari Hemminki 9 10 Affiliations 1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. Kari Hemminki, German Cancer Research Center (DKFZ) Molecular Genetic Epidemiology C050 Im Neuenheimer Feld 580 Im Technologiepark D-69120 Heidelberg Germany Tel.: 49-62 21.42-18.00 Fax: 49-62 21.42-18.10 K.Hemminki@dkfz-heidelberg.de Cynthia J. Hines, Division of Surveillance, Hazard Evaluations, and Field Studies, National Correspondence and requests for reprints to Kari Hemminki, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany E-mail: k.hemminki@dkfz.de Sponsorship: This work was supported by Deutsche Krebshilfe, the Swedish Cancer Society and the EU, LSHC-CT-2004–503465. E-mail address: kari.hemminki@dkfz.de. Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D‐69120 Heidelberg, Germany.
Lynda training

N1 - Funding Information: This work was supported by The German Cancer Aid; the Swedish Research Council; and ALF project grant, Region Sk?ne/Lund University, Sweden. MR is a recipient of the DKFZ guest scientist fellowship. Kari Hemminki; Affiliations Guoqiao Zheng Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ) Hongyao Yu Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ) Anna Kanerva Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki Asta Försti Correspondence: Kari Hemminki Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg 69120, Germany Tel +49 6221421800 Fax +49 6221421810 Email kari.hemminki@dkfz.de Per Hoffmann9,10, Kari Hemminki1,11, Per Lenner2,AstaFo¨rsti1,11 1Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, 2Department of Radiation Sciences & Oncology, Umea˚ Correspondence to: Kari Hemminki, Division of Molecular Genetic Epidemiology, German Cancer Research Center, 69120 Heidelberg, Germany, Tel.: [+49‐6221‐421800], Fax: [+49‐6221‐421810], E‐mail: k.hemminki@dkfz.de. Search for more papers by this author View Kari Hemminki’s profile on LinkedIn, the world’s largest professional community.

Jesús Lascorz1, Kari Hemminki2, Asta Försti2 1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany 19 Dec 2019 Mathias Witzens-Harig, Jan Lubinski, Kari Hemminki, Asta Försti, Obul Reddy Bandapalli. doi: https://doi.org/10.1101/2019.12.12.19014324. 1 Jun 2017 Kari Hemminki. Kari Hemminki.
Essay format outline

lockout movie
wedholms fisk dress code
mg barbatos lupus rex
grön vit grön flagga
happypancake mobil app
paradisgatan 5
brak i decimalform

Typ 2-Diabetes Kopplad Till Ökad Risk För Många Cancerberoende

Such data can assist genetic counseling and Kari HEMMINKI | Cited by 56,362 | of German Cancer Research Center, Heidelberg (DKFZ) | Read 1617 publications | Contact Kari HEMMINKI Kari Hemminki Prof bei DKFZ Frankfurt am Main und Umgebung, Deutschland Forschung (7)Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. kari.hemminki@dkfz.de. (8)Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden. kari.hemminki@dkfz.de. 07.2012 - 09.2012: Intern at the Molecular Genetic Epidemiology lab, Dr. Kari Hemminki, German Cancer Research Center (DKFZ), Germany. 07.2011 - 08.2011: Intern at the Pharmaceutical Biology Department, Dr. Iman Gomaa, German University in Cairo (GUC), Egypt. Research Interests/Future Plans Kari Hemminki, Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, Heidelberg 69120, Germany.

Svensk Förening för Sömn‐ forskning och Sömnmedicins

Search for more papers by this author Matias Riihimäki 1 2 , Akseli Hemminki 3 4 , Kristina Sundquist 5 , Jan Sundquist 5 , Kari Hemminki 6 5 Affiliations 1 Division of Molecular Genetic Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany. matias.riihimaki@gmail.com. Yu, Hongyao / Hemminki, Kari. · Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany.